<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tani</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Komeno</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Fukuma</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Fukushi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Taniguchi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shimojima</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2018</year>). 
  <article-title>Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: dose-efficacy studies upon oral administration</article-title>. 
  <source>PLoS ONE</source>
  <volume>13</volume>:
  <fpage>e0206416</fpage>. 
  <pub-id pub-id-type="doi">10.1371/journal.pone.0206416</pub-id>
  <?supplied-pmid 30365543?>
  <pub-id pub-id-type="pmid">30365543</pub-id>
 </mixed-citation>
</ref>
